{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:52:21Z","timestamp":1790121141493,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12888-016-0874-x","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T04:43:19Z","timestamp":1464237799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Lithium carbonate as a treatment for paliperidone extended-release-induced leukopenia and neutropenia in a patient with schizoaffective disorder; a case report"],"prefix":"10.1186","volume":"16","author":[{"given":"Hiroki","family":"Matsuura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohei","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Naemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Yamamuro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"issue":"1","key":"874_CR1","first-page":"102.e3","volume":"35","author":"G Manfredi","year":"2013","unstructured":"Manfredi G, Solfanelli A, Dimitri G, Cuomo I, Sani G, Kotzalidis GD, et al. Risperidone-induced leukopenia: a case report and brief review of literature. Gen Hosp Psychistry. 2013;35(1):102.e3\u20136.","journal-title":"Gen Hosp Psychistry"},{"issue":"2","key":"874_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eurpsy.2003.03.009","volume":"19","author":"M Sluys","year":"2004","unstructured":"Sluys M, Guzelcan Y, Casteelen G, de Haan L. Risperidone-induced leucopenia and neutropenia: a case report. Eur Psychiatry. 2004;19(2):117.","journal-title":"Eur Psychiatry"},{"issue":"1","key":"874_CR3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/00004850-200101000-00007","volume":"16","author":"N Buchman","year":"2001","unstructured":"Buchman N, Strous RD, Ulman AM, Lerner M, Kotler M. Olanzapine-induced leukopenia with human leukocyte antigen profiling. Int Clin Psychopharmacol. 2001;16(1):55\u20137.","journal-title":"Int Clin Psychopharmacol"},{"issue":"6","key":"874_CR4","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.pnpbp.2005.04.025","volume":"29","author":"V Stergiou","year":"2005","unstructured":"Stergiou V, Bozikas VP, Garyfallos G, Nikolaidis N, Lavrentiadis G, Fokas K. Olanzapine-induced leucopenia and neutropenia. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(6):992\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"8","key":"874_CR5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3109\/00048674.2010.495707","volume":"44","author":"J Alexander","year":"2010","unstructured":"Alexander J, Tibrewal P. Quetiapine-induced leucopenia. Aust N Z J Psychiatry. 2010;44(8):767\u20138.","journal-title":"Aust N Z J Psychiatry"},{"issue":"1","key":"874_CR6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.pnpbp.2006.07.003","volume":"31","author":"C Cowan","year":"2007","unstructured":"Cowan C, Oakley C. Leukopenia and neutropenia induced by quetiapine. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):292\u20134.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"874_CR7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pnpbp.2010.09.018","volume":"35","author":"JN Kim","year":"2011","unstructured":"Kim JN, Lee BC, Choi IG, Jon DI, Jung MH. Paliperidone-induced leukopenia and neutropenia: a case report. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(1):284\u20135.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"874_CR8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0004867412460594","volume":"47","author":"V Raj","year":"2013","unstructured":"Raj V, Druitt T, Purushothaman S, Dunsdon J. Risperidone\/paliperidone induced neutropenia and lymphopenia. Aust N Z J Psychiatry. 2013;47(3):291\u20132.","journal-title":"Aust N Z J Psychiatry"},{"key":"874_CR9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1192\/bjp.172.1.82","volume":"172","author":"B Sperner-Unterweger","year":"1998","unstructured":"Sperner-Unterweger B, Czeipek I, Gaggl S, Geissler D, Spiel G, Fleischhacker WW. Treatment of severe clozapine-induced neutropenia with granulocyte colony-stimulating factor (G-CSF): remission despite continuous treatment with clozapine. Br J Psychiatry. 1998;172:82\u20134.","journal-title":"Br J Psychiatry"},{"issue":"3","key":"874_CR10","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/104454603322572697","volume":"13","author":"A Sporn","year":"2003","unstructured":"Sporn A, Gogtay N, Ortiz-Aguayo R, Alfaro C, Tossell J, Lenane M, et al. Clozapine-induced neutropenia in children: management with lithium carbonate. J Child Adolesc Psychopharmacol. 2003;13(3):401\u20134.","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"874_CR11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0013-7006(04)95473-5","volume":"30","author":"F Papetti","year":"2004","unstructured":"Papetti F, Darcourt G, Giordana JY, Spreux A, Thauby S, Feral F, et al. Treatment of clozapine-induced granulocytopenia with lithium (two observations). Enc\u00e9phale. 2004;30(6):57\u201382.","journal-title":"Enc\u00e9phale"},{"issue":"Suppl 1","key":"874_CR12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hup.917","volume":"23","author":"RJ Flanagan","year":"2008","unstructured":"Flanagan RJ, Dunk L. Haematological toxicity of drugs used in psychiatry. Hum Psychopharmacol. 2008;23 Suppl 1:27\u201341.","journal-title":"Hum Psychopharmacol"},{"issue":"6","key":"874_CR13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1345\/aph.1C381","volume":"37","author":"KS Vesta","year":"2003","unstructured":"Vesta KS, Medina PJ. Valproic acid-induced neutropenia. Ann Pharmacother. 2003;37(6):819\u201321.","journal-title":"Ann Pharmacother"},{"key":"874_CR14","unstructured":"INVAGA\u00ae prescribing information. July 2009. Available from http:\/\/www.janssencns.com\/invega-prescribing-information . (Accessed on 13 Jan 2010)."}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-016-0874-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T15:03:43Z","timestamp":1498316623000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-016-0874-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["874"],"URL":"https:\/\/doi.org\/10.1186\/s12888-016-0874-x","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]},"article-number":"161"}}